Skip to content
777 Sourcing.

Capability

drug formulation/CMC development

Suppliers
1
States & provinces
1
Countries
1

1 drug formulation/cmc development supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

CHRYSALIS BIOTHERAPEUTICS INC

GALVESTON, TX

Chrysalis BioTherapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of treatments for serious respiratory disorders and acute radiation exposure. It develops regenerative peptide drugs, led by TP508 (Rusalatide acetate, Chrysalin), to restore vascular function and activate stem cells. Incorporated in Delaware in 2012, it is based in Galveston, Texas.

clinical trialspeptide drug developmentpreclinical studies

Compiled from public sources

Related capabilities

Other processes offered by the shops that list drug formulation/CMC development.

Browse all capabilities